Saturday November 21 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«PharMingen Norway

Below is an extended PharMingen Norway news listing. Click here to return to the PharMingen Norway main Biocorporate entry.

BioNews Results for PharMingen Norway:
BeautifulPeople.Com Declares Britons the World's Ugliest! MedIndia: Nov 14 2009 8:32AM Matching: norway
Genetic changes shown to be important indicators for disease progression in cervical cancer patients EurekAlert!: Nov 13 2009 2:31AM Matching: norway
Genetic changes shown to be important indicators for disease progression in cervical cancer patients Genetic Engineering News: Nov 13 2009 2:22AM Matching: norway
http://www.iam-magazine.com/reports/Detail.aspx?g=0a2998ad-09e8-4822-9773-8dff6549987c Intellectual Asset Management: Nov 13 2009 7:13PM Matching: norway
Mayor in London 'to promote pig biotech' Southland Times: Nov 13 2009 6:57PM Matching: norway
Ipsen's Decapeptyl 6-Month Formulation Receives Marketing Authorization in France for the Treatment of Locally Pharma Live: Nov 13 2009 9:38PM Matching: norway
French Authorities Approve Six-Month Formulation of Debiopharm and Ipsens Prostate Cancer Drug Genetic Engineering News: Nov 13 2009 6:05PM Matching: norway
Boehringer Ingelheim Corporation's Desire Drug May Prove Sex Really Is All in Her Head BioSpace: Nov 13 2009 5:50PM Matching: norway
Brightstar Expands Android Developer Device Global Distribution Program Freshnews.com: Nov 13 2009 5:24PM Matching: norway
Laser Therapy Seems to Relieve Neck Pain KSLA: Nov 13 2009 2:52PM Matching: norway
Ipsens Decapeptyl 6-Month Formulation Receives Marketing Authorization in France for the Treatment of Locally Advanced or Metastatic Prostate Cancer Yahoo! Canada: Nov 13 2009 8:20AM Matching: norway
Former Experiment Group Leader and family planning advocate loses battle with cancer World Learning: Nov 13 2009 7:11AM Matching: norway
Ipsens Decapeptyl 6-Month Formulation Receives Marketing Authorization in France for the Treatment of Locally Advanced or Metastatic Prostate Cancer Business Wire UK: Nov 13 2009 7:08AM Matching: norway
Ipsens Decapeptyl 6-Month Formulation Receives Marketing Authorization in France for the Treatment of Locally Advanced or Metastatic Prostate Cancer Business Wire UK: Nov 13 2009 7:07AM Matching: norway
Ipsens Decapeptyl 6-Month Formulation Receives Marketing Authorization in France for the Treatment of Loc Genetic Engineering News: Nov 13 2009 6:45AM Matching: norway

«PharMingen Norway

This page contained an extended PharMingen Norway news listing. Click here to return to the PharMingen Norway main Biocorporate entry.

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.